Semaglutide vs Retatrutide
Semaglutide is approved and widely prescribed. Retatrutide is still experimental. How they differ, and why their trial results cannot be lined up directly.
Side-by-side facts · No recommendation · Reviewed
SemaglutideRetatrutideSame for both
| Semaglutide | Retatrutide | |
|---|---|---|
| Acts on | GLP-1 receptor | GIP, GLP-1 and glucagon receptors |
| Status | FDA-approved (Ozempic, Wegovy, Rybelsus) | Investigational, not approved anywhere |
| Legitimate supply | Prescription | None outside clinical trials |
| Forms | Weekly injection; daily tablets | Weekly injection in trials |
| Evidence | Large published trials, including a head-to-head trial against liraglutide | Phase 3 results announced in 2026, not yet peer-reviewed |
Why the numbers are not comparable
No trial has compared the two directly. In the STEP 8 trial, average weight loss with semaglutide was 15.8% at 68 weeks. Retatrutide’s phase 3 trials reported up to 22.6% at 80 weeks in one trial.
Different trials enroll different people, run for different lengths of time and measure in different ways, so these figures cannot be set side by side as if they came from one study. Retatrutide’s full results have not yet been published in a peer-reviewed journal or reviewed by FDA.
Side effects
Both cause mainly stomach and bowel side effects. Semaglutide’s label carries a boxed warning about thyroid C-cell tumors seen in rodents. In retatrutide trials, 13.5% of people on the highest dose stopped because of side effects, compared with 4.8% on placebo, and trials also recorded altered skin sensation.
Availability
Semaglutide is available on prescription. Retatrutide is not legitimately available to patients anywhere. Anything sold online as retatrutide comes from outside the approved supply chain, with no assurance of identity, strength or sterility.
Questions
Is retatrutide stronger than semaglutide?
No head-to-head trial exists, and retatrutide’s results are not yet peer-reviewed or reviewed by FDA, so that cannot be answered yet.
Can retatrutide be prescribed?
No. It is investigational and not approved anywhere. It is available only inside clinical trials.
Is retatrutide sold online real?
There is no approved product. Products sold online have no assurance of identity, strength or sterility.
Which compound, if any, suits a person is a decision for them and a licensed prescriber. This page compares published facts and does not recommend either.
Sources: JAMA: STEP 8 trial (Rubino et al., 2022); Eli Lilly: TRIUMPH-2 and TRIUMPH-3 results; HCPLive: retatrutide phase 3 endpoints; Managed Healthcare Executive: GLP-1 pills; Prime Therapeutics: GLP-1 pipeline update, August 2026; Novo Nordisk: Wegovy and Saxenda safety information; Polsinelli: FDA compounded GLP-1 policy.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.